| Print
ROCHE I (RO)
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
Address
Grenzacherstrasse 124
Basel
CHE
4070
Telephone
+41 616875284
Forecast key dates
| Name | Key Date |
|---|---|
| Roche Holding AG Second Quarter Earnings Conference Call for 2027 | 2027-07-23T14:00:00 |
| Roche Holding AG Second Quarter Earnings Results for 2027 | 2027-07-23T00:00:00 |
| Roche Holding AG Annual General Meeting for 2027 | 2027-03-10T10:30:00 |
| Roche Holding AG Fourth Quarter Earnings Conference Call for 2026 | 2027-01-29T13:30:00 |
| Roche Holding AG Fourth Quarter Earnings Results for 2026 | 2027-01-29T07:00:00 |
| Roche Holding AG Annual Report for 2026 | 2027-01-28T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Roche Holding AG Second Quarter Earnings Conference Call for 2026 | 2026-07-23T14:00:00 |
| Roche Holding AG Second Quarter Earnings Result for 2026 | 2026-07-23T00:00:00 |
| Roche’s Virtual ADA Investor Event | 2026-06-08T17:00:00 |
| Roche Holding AG Annual General Meeting for 2026 | 2026-03-10T10:30:00 |
| Roche Holding AG Fourth Quarter Earnings Conference Call for 2025 | 2026-01-29T13:30:00 |
| Roche Holding AG Fourth Quarter Earnings Results for 2025 | 2026-01-29T07:00:00 |
| Roche Holding AG Annual Report for 2025 | 2026-01-28T00:00:00 |